Nosocomial infections are a significant, growing problem, and risk devaluing medical care. Several studies have shown that hospital acquired infections are starting to get worse, and while part of the problem is the rise in antibiotic resistant bacteria, other factors – like the increase in smartphone and tablet use – are also leading the charge in the spread of potentially deadly illness.

The costs associated with hospital acquired infection is extremely high. Estimates put the number somewhere between $9.8 billion and $45 billion every year treating HAIs, and those values appear to be rising at a rapid pace thanks in part to the challenges associated with technology in the medical community. The costs on a per-patient bases are also significant, with estimates that include:

  • Blood Stream Infections - $45,000 per patient.
  • Ventilator Related Pneumonia - $40,000 per patient.
  • Surgical Site Infections - $20,000 per patient.

In some cases the costs can be even worse, with difficulties like Staph and MRSA opening the door for lawsuits, follow up treatments, and the costs associated with HAI deaths.

Hospital Acquired Infections and Bacteria

Many of the bacteria that SmartSleeves protects against are on the top of the list for the most deadly or dangerous hospital acquired infections – possibly leading to costs that exceed the averages above. Examples include:

  • MRSA – Methicillin resistant staphylococcus aureas, or MRSA, represents one of the most deadly and frightening issues affecting hospitals today. In 1999, the average cost of a single MRSA infection was around $27,000, and that number has only increased in the past 15 years, with most estimates putting the total number at well over $40,000.
  • K. pneumonia - Hospital-acquired pneumonia is the second most common type of nosocomial infection, and the leading cause of death in hospitals. The exact cost ratio in 2015 is not known, but estimates put the number as much as $15,000 13 years ago, and – like with MRSA – the costs per person have only increased.
  • E. coli – Bloodstream infections caused by E. coli can be both dangerous and deadly. After 21 days, the mortality rate of E.Coli bloodstream infections is extremely high, with costs that may be well over $40,000.
  • Pseudomonas aeruginosa – At roughly $15,000 per patient, the cost of pseudomonas aeruginosa infections is extremely high, with 51,000 cases on average per year according to the CDC. In addition, more and more cases are becoming drug resistant, increasing the cost associated with the infection.

These are only some of the infections and costs that hospitals now have to consider each and every year. SmartSleeves helps protect against these infections and many others. Given the costs associated with only a single infection, as well as the harm to the patient, it is within the hospital’s best interests to strongly consider using SmartSleeves, and other protection, to ensure your clinic is less prone to nosocomial diseases.